10-year CVD risks as predicted by the risk scores at the start of statin treatment
| Categories of 10-year CVD risk as predicted by risk score | ||||||||
|---|---|---|---|---|---|---|---|---|
| Risk score | Mean 10-year CVD risk as predicted by risk score | Median 10-CVD year risk as predicted by risk score | Risk of 5<% | Risk of 5–10% | Risk of 10–15% | Risk of 15–20% | Risk of ≥20% | |
| Percentage of patients | Percentage of patients | Percentage of patients | Percentage of patients | Percentage of patients | ||||
| Framingham | <2007 | 17.7 | 15.9 | 6.9 | 19.0 | 20.6 | 18.4 | 35.1 |
| ASSIGN | 19.3 | 17.4 | 5.0 | 15.6 | 20.3 | 18.6 | 40.5 | |
| QRISK2 | 17.6 | 16.2 | 10.6 | 17.2 | 17.8 | 16.9 | 37.5 | |
| Any of the three risk scores (highest estimate) | 21.6 | 17.4 | 3.9 | 12.3 | 16.6 | 17.7 | 49.5 | |
| Framingham | ≥2007 | 16.8 | 15.6 | 6.7 | 18.5 | 22.2 | 20.9 | 31.7 |
| ASSIGN | 18.6 | 17.3 | 4.9 | 15.2 | 20.5 | 20.4 | 39.0 | |
| QRISK2 | 17.8 | 16.6 | 9.8 | 16.1 | 18.1 | 18.0 | 38.0 | |
| Any of the three risk scores (highest estimate) | 21.3 | 17.3 | 3.7 | 11.2 | 16.2 | 18.8 | 50.2 | |
CVD, cardiovascular disease.